Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 145

    1.

    The thrombophilias: well-defined risk factors with uncertain therapeutic implications.

    Bauer KA.

    Ann Intern Med. 2001 Sep 4;135(5):367-73. Review.PMID: 11529700 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Role of thrombophilia in deciding on the duration of anticoagulation.

    Bauer KA.

    Semin Thromb Hemost. 2004 Dec;30(6):633-7. Review.PMID: 15630669 [PubMed - indexed for MEDLINE]Related articles

    3.

    Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.

    Wåhlander K, Larson G, Lindahl TL, Andersson C, Frison L, Gustafsson D, Bylock A, Eriksson BI.

    Thromb Haemost. 2002 Apr;87(4):580-5.PMID: 12008938 [PubMed - indexed for MEDLINE]Related articles

    4.

    Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.

    Santamaria MG, Agnelli G, Taliani MR, Prandoni P, Moia M, Bazzan M, Guazzaloca G, Ageno W, Bertoldi A, Silingardi M, Tomasi C, Ambrosio GB; Warfarin Optimal Duration Italian Trial (WODIT) Investigators.

    Thromb Res. 2005;116(4):301-6. Epub 2005 Jan 26.PMID: 16038714 [PubMed - indexed for MEDLINE]Related articles

    5.

    Evidence-based indications for thrombophilia screening.

    Lindhoff-Last E, Luxembourg B.

    Vasa. 2008 Feb;37(1):19-30. Review.PMID: 18512539 [PubMed - indexed for MEDLINE]Related articles

    6.

    Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.

    Martinelli I, Battaglioli T, Razzari C, Mannucci PM.

    J Thromb Haemost. 2007 Jan;5(1):98-101. Epub 2006 Oct 25.PMID: 17067362 [PubMed - indexed for MEDLINE]Related articles

    7.

    Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis.

    Eckman MH, Singh SK, Erban JK, Kao G.

    Med Decis Making. 2002 Mar-Apr;22(2):108-24.PMID: 11958494 [PubMed - indexed for MEDLINE]Related articles

    8.

    The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis.

    Van Rooden CJ, Rosendaal FR, Meinders AE, Van Oostayen JA, Van Der Meer FJ, Huisman MV.

    Haematologica. 2004 Feb;89(2):201-6.PMID: 15003896 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Management of thrombophilia.

    Bauer KA.

    J Thromb Haemost. 2003 Jul;1(7):1429-34. Review.PMID: 12871277 [PubMed - indexed for MEDLINE]Related articles

    10.

    AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.

    Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.

    Haematologica. 2008 May;93(5):729-34. Epub 2008 Apr 2.PMID: 18387978 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Thrombophilia testing in patients with venous thrombosis.

    Caprini JA, Goldshteyn S, Glase CJ, Hathaway K.

    Eur J Vasc Endovasc Surg. 2005 Nov;30(5):550-5. Epub 2005 Aug 1.PMID: 16055356 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pregnancy-associated venous thromboembolism in combined heterozygous factor V Leiden and prothrombin G20210A mutations.

    Couto E, Nomura ML, Barini R, Pinto e Silva JL.

    Sao Paulo Med J. 2005 Nov 3;123(6):286-8. Epub 2006 Jan 20.PMID: 16444389 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.

    Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannucci PM.

    Thromb Haemost. 2001 Sep;86(3):800-3.PMID: 11583310 [PubMed - indexed for MEDLINE]Related articles

    15.

    Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.

    Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I.

    Health Technol Assess. 2006 Apr;10(11):1-110. Review.PMID: 16595080 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.

    Fábregues F, Tàssies D, Reverter JC, Carmona F, Ordinas A, Balasch J.

    Fertil Steril. 2004 Apr;81(4):989-95.PMID: 15066453 [PubMed - indexed for MEDLINE]Related articles

    17.

    Issues concerning the laboratory investigation of inherited thrombophilia.

    Tripodi A.

    Mol Diagn. 2005;9(4):181-6. Review.PMID: 16392896 [PubMed - indexed for MEDLINE]Related articles

    18.

    Management options for thrombophilias.

    Gallus AS.

    Semin Thromb Hemost. 2005 Feb;31(1):118-26. Review.PMID: 15706484 [PubMed - indexed for MEDLINE]Related articles

    19.

    Genetic thrombophilia.

    Feero WG.

    Prim Care. 2004 Sep;31(3):685-709, xi. Review.PMID: 15331254 [PubMed - indexed for MEDLINE]Related articles

    20.

    Inherited thrombophilias in pregnant patients: detection and treatment paradigm.

    Lockwood CJ.

    Obstet Gynecol. 2002 Feb;99(2):333-41. Review.PMID: 11814516 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data